For prednisone, newer, more targeted therapies that reduce side effects are being developed, along with improved formulations that could offer better control of inflammatory diseases with fewer systemic effects.
Therefore, we evaluate if the product has been tested by Informed Sport, NSF, or Banned Substance Control Group (BSCG) for banned substances
The drug is also used for weight loss
mechanism unexplained Relative contributions of direct peptide effects versus downstream IGF-1 actions inadequately characterized Long-term receptor sensitivity and potential for desensitization inadequately studied Individual patient variability in response not well-characterized Potential for differential effects based on endogenous growth hormone status unclear Long-Term Safety Considerations Critical safety questions remain unanswered regarding chronic peptide administration: Cardiovascular safety concerns FDA warnings cite risks of increased heart rate, systemic vasodilation, flushing, and transient hypotension Immunogenicity risks FDA identifies both peptides as potentially immunogenic with risk of serious immune reactions including anaphylaxis Cancer risk theoretical concern that chronic growth hormone/IGF-1 elevation could promote cellular proliferation
Your prescriber will gradually increase your dosage each week until you reach the target dose of 3 mg daily
Combining leptin treatment with leptin sensitizers may thus help overcome leptin resistance and, also obesity, as a result [14]